T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma.
Warren
E H
EH
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Tykodi
S S
SS
Murata
M
M
Sandmaier
B M
BM
Storb
R
R
Jaffee
E
E
Childs
R
R
Thompson
J A
JA
Greenberg
P D
PD
Riddell
S R
SR
D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D002986:Clinical Trials as Topic; D006086:Graft vs Host Disease; D020350:Graft vs Tumor Effect; D006801:Humans; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D015778:Minor Histocompatibility Antigens / Q000737:chemistry* / Q000276:immunology; D009362:Neoplasm Metastasis; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism
D015778:Minor Histocompatibility Antigens